Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial - Scheid, Christoph; Bertsch, Uta; Goldschmidt, Hartmut (Haematologica, 2014)
Gesehen am 03.06.2016